Humedica Launches Next-Generation Clinical Informatics Platform
BOSTON, MA
Humedica, a next-generation health care informatics company, announced the company’s official launch, along with the previous completion of its $30 million round of venture capital and its clinical analytics platform.
In response to a growing demand for essential clinical information, Humedica has developed a clinical informatics solution that addresses the specific needs of inpatient and outpatient health care providers, pharmaceutical and biotechnology firms, medical device manufacturers, government agencies and financial services firms. Currently being implemented in select hospitals and medical groups throughout the country, Humedica’s software-as-a-service (SaaS) solution connects patient information across varied medical settings and time periods to generate a comprehensive view of patient care.
“...Humedica offers a complete picture of health care delivery, bringing together clinical, operational, and financial data to help answer both pressing real-time questions and to address topics at the center of health care reform that require comparative analyses and benchmarking information,” said Michael Weintraub, President and CEO of Humedica.
Humedica has developed an analytics platform that effectively overcomes barriers of accessing relevant clinical information, transforming real-time and retrospective data into actionable knowledge. Humedica applies sophisticated techniques to mine, standardize, and aggregate health care data from disparate IT systems, all within a HIPAA-compliant, and highly secure environment.
Humedica’s SaaS-based clinical informatics portfolio offers analytics, reporting, and benchmarking.
The company also disclosed it received $30 million in capital from Bain Capital Ventures, General Catalyst Partners, North Bridge Venture Partners, and Leerink Swann.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
